A competitive nested PCR-temperature gradient gel electrophoresis protocol (nPCR/TGGE) has been established for the quantification of human cytomegalovirus (HCMV) target sequences. The measurement was achieved by co-amplification of a defined copy number of an internal standard (st) and separation of st and wildtype (wt) amplimers by temperature gradient gel electrophoresis (TGGE). The number of HCMV target sequences could be precisely determined within wt/st ratios of 0.1 to 10. With 50 copies of the st sequence the detection limit of nPCR/TGGE was found to be five to l0 copies of the target sequence. Effects of sample preparation on quantitative HCMV PCR were minimized by the additional quantification offl-globin target sequences and calculation of the ratio of HCMV copies/fl-globin copies. Serial peripheral blood leukocyte specimens of 17 renal allograft recipients positive in a qualitative nested HCMV PCR were tested using nPCR/TGGE. Thirty healthy blood donors served as negative controls. Positive results were obtained by nPCR/TGGE in nine renal allograft recipients but in none of the healthy blood donors. Five of five patients with an HCMV pp65 antigenaemia and positive for HCMV IgM were positive in nPCR/TGGE. The highest HCMV/fl-globin ratios (10000 to 8000 copies HCMV/ 106 copies fl-globin) were found in transplant recipients experiencing acute clinically symptomatic HCMV infection. HCMV DNA levels in asymptomatic patients ranged from 900 to 200 copies HCMV/10 ~ fl-globin.
Introduction
During recent years PCR protocols for the detection of numerous human viral and non-viral pathogens have been established (for review, see Xu & Larzul, 1991) . Generally, the ability to demonstrate the presence of viruses in clinical samples with an unprecedented sensitivity has been the driving force for using PCR as a novel diagnostic procedure.
Problems are encountered, however, if PCR is employed for the detection of viruses that establish lifelong latency in the host interrupted by episodes of recurrences. Thus, during acute infection with human cytomegalovirus (HCMV), viral DNA is readily detected by PCR in peripheral blood mononuclear cells (PBMCs), biopsies, serum, urine and various other specimens (Brytting et al., 1992; Demmler et al., 1988; Jiwa et al., 1989a, b; Rogers et al., 1990; Shibata et al., 1988) , but positive results may be obtained during asymptomatic reactivations and in latently infected healthy individuals as well (Bevan et at., 1991) . Therefore, without further laboratory and clinical data, positive PCR results are difficult to interpret.
The predictive value of a single positive HCMV PCR result from peripheral blood samples has been reported to be low (Delgado et al., 1992) . Thus, the diagnostic significance of HCMV PCR in peripheral blood seems to be restricted to detection in individuals at risk of reactivated HCMV infection (Zipeto et al., 1992) .
Assuming that, in general, levels of HCMV DNA are lower in latently infected individuals than in patients with acute clinically symptomatic infections, the quantification of HCMV target sequences present in a sample may be a useful approach to minimize false positive results due to latent virus. In addition, determination of the amount of viral target sequences should permit better monitoring of disease progression and of antiviral therapies (Einsele et al., 1991) . Presently, only limited data have been reported on the quantitative or semiquantitative determination of HCMV copy numbers in clinical samples (Fox et al., 1992; Shibata et al., 1992; Cagle et al., 1992) . 5"GCGAATTCGGAAACGATGGTGTAGTTCG 3' 5"CGGAAACGATGGTGTAGTTCG 3" 5" GTCAAGGATCAGTGGCACAGC 3' 5" GTAGCTGGCATTGCGATTGGT 3' 5"ACCCGTGGAGACTGCAAAAAAATG 3' 5"CATTTTTTTGCAGTCTCCACGGGT 3' 5'CCGGATCCCGCCGCCCGCCCCGCGCCCGCCGCGGCAGCACCTGGCT 3' 5'GCGAATTCGTAAACCACATCACCCGTGGA 3' 5'GCGAATTCGTAAACCACATCACCCGTGGAGACTGC 3'
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* Localization of HCMV and fl-globin primers indicated according to Cranage et al. (1986) and Orkia & Kazazian (1984) .
t Recognition sites for restriction enzymes used for subcloning and radioactive labelling are given in bold; primer mismatches are underlined.
Here, we describe quantification of HCMV target sequences using a technique comprising nested PCR and temperature gradient gel electrophoresis (nPCR/TGGE) (Henco & Heibey, 1990) . Using this methodical approach, even low numbers of HCMV genomes in clinical samples can be exactly measured.
Methods
Patient population and routine diagnostic procedures for the detection of acute HCMV infections. Renal allograft recipients attending the university hospital of Heidelberg were tested for the occurrence of acute HCMV infections, as described earlier (Kfihn et al., 1991) .
Briefly, HCMV-specific IgM and IgG antibodies were determined by ELISA (Zytomegalie Enzygnost, Behring), human diploid fibroblast cultures were monitored for the appearance of immediate early fluorescent foci 24 h and 48 h after inoculation with urine samples [detection of early antigen fluorescent foci (DEAFF; Griffith et al., 1984) ] and HCMV pp65 antigen was demonstrated in peripheral blood leukocytes (PBLs) . For the detection of HCMV pp65 and immediate early antigen, monoclonal antibodies Clonab (Biotest) and 9221 (DuPont), respectively, were used.
Extraction of DNA from clinical samples. To obtain total DNA extracts from PBLs, 200 lal of citrate blood was mixed with 800 lal of TE buffer (10 mi-Tris-HCl, 1 mM-Na2EDTA , pH 8.0) and incubated for 30 min on ice. Samples were centrifuged for 10 min at 4 °C and 12000g, and pellets were washed twice with 1 ml cold TE buffer and resuspended in 200 lal proteinase K buffer containing 67 mM-Tris-HC1 pH 8.8, 3 mM-MgCI2, I0 mM-2-mercaptoethanol, 1% Triton X-100 (Sigma), and 100 gg/ml proteiaase K (Boehringer Mannheim). Samples were incubated for 1 h at 55 °C. After boiling for 10 min and the pelleting of insoluble material, 5 lal samples of the supernatants were employed in quantitative PCR.
PBMCs were isolated by Ficoll-Paque (Pharmacia-LKB) density gradient centrifugation. Two ml of citrate blood was mixed with 2 ml of sterile 0-9 % NaC1 and carefully layered onto 3 ml of the separation medium. After centrifugation at 400 g for 30 min the interphase was recovered, resuspended in sterile PBS, and cells were pelleted at 400 g for 15 min. The pellet was washed twice with PBS, and cells were resuspended in proteinase K buffer. Digestion with proteinase K and extraction of DNA were performed as described above.
DNA from organ biopsies was extracted by carefully mincing approx. 50 mg of tissue on ice. After homogenizing the samples were suspended in 200 gl proteinase K buffer and treated as described above.
Tissue culture supernalants were boiled for 5 rain, and insoluble material was pelleted before PCR.
Prior to quantitative PC R, I0 lai of TE buffer containing the desired copy number of HCMV and fl-globin internal standard (st) sequences (see below) was added to 5 gl or 10 gl of extracts.
Cloning of wild-type and st sequences for nPCR/TGGE. The 268 bp external wild-type (wt) sequence, the 268 bp external st sequence and the 157 bp internal st sequence were generated by PCR and subcloned into the vector pSPT 19 (Boehringer Mannheim). In these experiments, purifed linearized DNA of plasmid pBSXC4 (kindly provided by M. Mach, Erlangen, Germany) containing the entire coding region of HCMV AD169 glycoprotein B (gB) (Cranage et al., 1986; Mach et al., 1986) served as a target sequence. The external 268 bp wt HCMV gB fragment ranging from nucleotide positions 655 to 922 within gB (positions given from start codon) was amplified with primers E1B and E2E. Primer sequences are given in Table 1 .
St sequences carrying an A to G exchange at position 802 in the sense strand were generated in PCR by site-directed mutagenesis (Higuchi, 1990 ). The 157 bp internal st sequence containing the 19 bp GC clamp was generated and cloned using primers TGGE1B/TGGE2MUT.
The mutation within the 268 bp external st sequence employed in nPCR was introduced by elongation of two purified overlapping PCR fragments created with the primer pairs E1B and MUT1, and E2E and MUT2, respectively, and subsequent reamplification of the product with primers E1B and E2E.
Sequence analysis of the cloned 268 bp wt sequence, pBSXC4, and amplimers of HCMV AD169-infected fibroblasts showed that the amplified wt sequence varied from the published sequence at positions 781 (C to T), 803 (C to T) and 804 (T to C). As a consequence, the cloned st and wt sequences differed in three adjacent positions, i.e. ACT at positions 802 to 804 in the wt sequence instead of GTC in the st sequence. The C to T exchange at position 781 was present in wt and st sequences.
Cloning offl-globin wt and st sequences has been previously reported (Henco & Heibey, 1990) . Purified plasmid DNA containing the HCMV and fl-globin st sequences was linearized, HPLC-purified, quantified by u.v.-spectrophotometry at 260 nm and 280 nm, and diluted to the desired copy number. Multiple aliquots were stored at -20 °C until use.
Radioactive labelling of st sequences. Probe with strand-specific labelling was prepared as described earlier (Kang et al., 199l) . Briefly, purified plasmid DNA containing the internal HCMV or fl-globin st sequences was cleaved with EcoRI, and recessed ends were filled with [c~-32P]dATP and trapped with dTTP. Unincorporated dNTPs were removed by gel filtration on a 3 ml Sephadex G-50 column (Pharmacia-LKB). Fractions containing labelled plasmid DNA were pooled, precipitated with ethanol, and recut with BamHI.
Amplification ofDNA. PCR was performed essentially as described earlier (Kfihn et al., 1991 ; Gass et al., 1993) . Primer sequences are given in Table 1 . Nested HCMV PCR was carried out for 20 cycles using the external primers E1 and E2. Five lal of each reaction mix was transferred from external to internal PCR, and samples were reamplified for another 30 cycles either with the internal primers TGGE1B and TGGE2E in nPCR/TGGE or with the internal primers I 1 and I2 in qualitative nPCR. fl-globin sequences were amplified with the primers laB and lbE (30 cycles). The final concentrations of primers El, E2, TGGE1B, TGGE2E, I1, I2, lab and lbE were 1.0/aM.
The detection limit of the qualitative nested HCMV PCR (primers El, E2, I1, I2) was estimated to be one to five copies of the HCMV target sequence in 0.5 lag human DNA (data not shown).
To avoid PCR product carry-over the suggestions of Kwok (1990) were carefully considered. Namely, pre-and post-PCR steps were performed in strictly separated areas. During nested PCR, gloves were changed after each pipetting step and positive displacement pipettes were used.
To exclude false negative PCR results due to strain variations within the primer binding sites, cell lysates of 65 clinical HCMV isolates were amplified in nested PCR, and amplimers were separated and detected on ethidium bromide-stained agarose gels. Positive results were obtained with all HCMV isolates. Cell controls and lysates of herpes simplex virus-, varicella-zoster virus-, human herpesvirus 6-and Epstein-Barr virus-infected cells remained negative.
Separation of PCR amplimers by parallel TGGE.
After PCR, amplimers were either directly subjected to analysis by TGGE or stored at -20 °C until use. Four lal of each reaction mix was added to 4 ~tl of denaturation/renaturation buffer containing 400 mM-MOPS pH 8.0, 8 M-urea, 10 mM-Na~EDTA pH 8.0 and 3000 c.p.m, of internal st sequences with strand-specific labelling. Samples were boiled for 5 min and renatnred at 50 °C for 20 min. Before electrophoresis, 2/.tl of 5 x DNA sample buffer (50% sucrose, 0.1% bromophenol blue, 0.1% xylene cyanol) was added.
TGGE was performed on 1 mm flat-bed denaturing 8% polyacrylamide gels (acrylamide and bisacrylamide at a ratio of 60: 1) containing 8 M urea, 2 % glycerol, 20 raM-MOPS pH 8-0 and 1 mMNa2EDTA. Gels were polymerized onto Gel-bond films (Biozym) and placed onto the thermoplate of the TGGE apparatus (Diagen). A linear temperature gradient was created parallel to the direction of electrophoresis (parallel TGGE). The cathode and anode were at the cold and hot poles, respectively. Twenty mM-MOPS pH 8.0 and 1 mMNa~EDTA served as electrophoresis buffer.
The separation of PCR products by TGGE was optimized in preliminary experiments. Best results were achieved with a linear temperature gradient from 20 °C to 60 °C, and electrophoresis at 300 V for 3.75 h. Under these conditions, a difference in the electrophoretic mobility of homoduplex and heterodnplex bands of approximately 20 % was obtained.
After electrophoresis, gels were washed twice with 10 % ethanol and 1% acetic acid for 5 min, dried for 2 h at 50 °C, and exposed to X-ray films (XAR-5 films, Kodak). Finally, the intensities of bands on the autoradiographs were measured and background activities were subtracted by densitometric scanning and computer-assisted processing using a Scan Jet Plus (Hewlett Packard), an Apple Macintosh II, and Microsoft Excel.
The amount of wt target sequences present in a sample before PCR was calculated by multiplying the ratio of wt/st signals by the number of st sequences added.
Results

Principle of quantification of target sequences by nPCR/TGGE
The use of nPCR/TGGE to measure the number of target sequences has been described previously in detail (Henco & Heibey, 1990) . Fig. 1 schematically depicts the methodical approach of nPCR/TGGE.
Briefly, a defined copy number of st sequences is coamplified in each sample. The st sequences differ from the wt sequences to be quantified by one or more base exchanges. After PCR, amplimers are hybridized to a small amount of strand-specifically labelled st sequence (probe). The probe forms heteroduplexes containing base mismatches with amplified wt sequences and perfectly matched homoduplexes with amplified st sequences. Next, samples are separated on flat-bed denaturing polyacrylamide gels with an imposed temperature gradient (parallel TGGE; Riesner et at., 1989) .
During TGGE heteroduplexes start to melt at lower temperatures and show a reduced electrophoretic mobility as compared to homoduplexes. The number of wt sequences present in a sample before PCR is determined by multiplying the ratio of wt signal/st signal with the number of st sequences added.
Quantification of HCMV target sequences
The capacity of nPCR/TGGE to quantify small amounts of HCMV target sequences was tested by adding 100, 50, 20 or 10 copies of the st sequence to serial dilutions of purified plasmid DNA containing 10000 to 10 copies of the wt HCMV target sequences. St and wt sequences were co-amplified in nPCR, hybridized to labelled st sequence, and separated by TGGE as described in Methods. Results of these experiments are given in Fig.  2(a, b) . It was demonstrated that even low numbers of HCMV target sequences can be precisely quantified by nPCR/TGGE. Depending on the number of st sequences added, the overall sensitivity was found to be ~< 10 copies of the wt sequence.
To allow an estimation of the accuracy and inter-assay variation of HCMV nPCR/TGGE, aliquots containing 1000 molecules of the st sequence and 100, 1000 or 10000 molecules of the wt target sequence were repeatedly tested. The means of five independent experiments were 0.1, 0-98 and 10.02 for wt/st ratios of 0.1, 1.0 and 10, respectively. The S.D. was calculated to be less than 3 % of the theoretically expected values at wt/st ratios of 0'1 and 1.0, and approximately 17% for a wt/st ratio of 10 (data not shown).
With low copy numbers of the target sequences, however, higher deviations of the experimentally determined wt/st ratios from the theoretically expected values were observed (Fig. 2 b) . This was considered to be most likely due to an uneven distribution of wt and st sequences at the lowest concentrations tested.
The dynamic range of nPCR/TGGE, i.e. wt/st ratios that can be accurately quantified with a given number of st sequences, was evaluated to be approximately two orders of magnitude, and ranged from wt/st ratios ~< 10 to ~> 0.1 (Fig. 3) .
To demonstrate an equal amplification of st and wt sequences during PCR, a fixed ratio of wt and st amplimers was serially diluted 10-fold and re-amplified in PCR (30 cycles). Dilution and re-amplification of amplimers was repeated twice. The initial ratio of wt and st sequences (0.57) remained virtually unchanged even after 90 PCR cycles and an estimated overall amplification rate of 1023 (final wt/st ratio 0-65) (data not shown). 
Quantification of fl-globin copy numbers and determination of the ratio of HCMV/fl-globin sequences
Fluctuations in the total leukocyte number present in a sample or in the efficiency of DNA extraction from cells are likely to alter the results of quantitative determination of cell-associated viral target sequences. As a possible strategy to minimize these inadvertent effects, the additional measurement of the cellular single-copy gene for fl-globin in PBL extracts by nPCR/TGGE and calculation of the ratio of viral sequences per cell genome was evaluated. Fig. 4 shows that a linear correlation exists between the number of PBMCs present in a sample before extraction of cellular DNA and the quantitative determination offl-globin sequences by nPCR/TGGE. In a further experiment, an HCMV PCR-positive kidney biopsy containing approximately 200 copies HCMV/ 10 lal extract was serially diluted twofold prior to quantification of HCMV and fl-globin sequences ( Table  2 ). The ratio of HCMV/fl-globin sequences in the undiluted extract was 2050 copies HCMV/106 copies t- Table 3. globin. Using 200 copies of the HCMV st sequences, the highest dilution that allowed measurement of HCMV target sequences was 1:16. A moderate dilution of the sample, i.e. up to fourfold, had no significant influence on the HCMV/fl-globin ratio. At higher dilutions of the sample, i.e. eight-to 16-fold, more deviation of the experimentally determined HCMV/fl-globin ratios from the theoretically expected values was observed. Nevertheless, even near the detection limit of nPCR/TGGE, acceptable estimations of the initial HCMV/fl-globin ratio were obtained (errors less than 30 %). Quantitative determination of fl-globin copy numbers and calculation of the ratio of HCMV copy numbers/flglobin copy numbers were therefore used to monitor and correct the results of quantitative HCMV PCR in PBL extracts. :~ (a) HCMV copy number in 5 gl of PBL extract (50 copies of the HCMV st sequence were added); (b) fl-globin copy number in 5 gl of PBL extract (104 copies of the fl-globin st sequence were added); (c) number of HCMV sequences per 10 ~ fl-globin copies (to the nearest hundred). § Owing to the low level of fl-globin sequences, quantification was performed with 103 copies of the st sequence. Fig. 5(a, b) . Approximately l0 weeks after transplantation, this patient developed clinical symptoms Patient indicative of HCMV infection. According to a seroconversion and a significant rise in HCMV-specific IgM and IgG antibodies (detected in ELISA), detection of pp65 antigen in peripheral blood, and demonstration of 22~ HCMV in urine by the DEAFF technique (see Methods), an acute primary HCMV infection was diagnosed.
Quantification of HCMV sequences in PBL extracts of renal allograft recipients
3 On day 79 after transplantation an HCMV-specific antiviral therapy (Ganciclovir at 500mg/day) was 4 started and maintained for 10 days. Two PBL extracts obtained 73 and 80 days after transplantation gave 5 positive results in HCMV PCR. In these samples 6 approximately 50 and 150 copies HCMV DNA/5 t~1 of 7 PBL extract, respectively, were detected. Further samples obtained after the onset of intravenous Ganciclovir 8 therapy were negative in nPCR/TGGE (Table 3) . 9 Positive results in qualitative nested HCMV PCR were 10 obtained at 31, 73, 80 and 83 days after transplantation, ll to 17 Table 4 summarizes the results of quantitative determination of HCMV target sequences in PBL extracts of 17 HCMV PCR-positive renal allograft recipients. None of the patients had clinical signs of acute rejection of the transplant. From all patients at least three consecutive samples were available for analysis in quantitative HCMV and fl-globin PCR.
Three of the 17 patients tested had clinical symptoms indicative of an acute HCMV infection, e.g. fever, leukopenia and thrombocytopenia. HCMV infection was confirmed by routine diagnostic procedures in all three cases. The highest levels of HCMV target sequences (Table 4 ). The absolute number of HCMV target sequences per 5 gl PBL extract did not correlate with the outcome of other diagnostic procedures or the development of clinical symptoms. Thus, PBL extracts of patient 3, who suffered from a symptomatic HCMV infection with severe leukopenia and thrombocytopenia, contained only low levels of HCMV target sequences, e.g. approximately 10 copies of the HCMV target sequence per 5 lal of extract. However, the ratio of HCMV//%globin sequences (8000 copies HCMV/106 copies ]%globin) was similar to the HCMV/fl-globin ratios of patients 1 and 2 who also experienced an acute clinically symptomatic HCMV infection.
Eight patients were positive in qualitative nPCR but negative in nPCR/TGGE. All of these patients were clinically asymptomatic, and tested negative for pp65 antigen or HCMV IgM. In one patient, excretion of HCMV into the urinary tract could be detected by DEAFF (Table 4) .
Quantification of HCMV in PBLs of healthy blood donors
PBL extracts of 30 healthy blood donors, 14 HCMV IgG-positive and 16 HCMV IgG-negative, were analysed in nPCR/TGGE and qualitative nPCR. All specimens remained negative in nPCR/TGGE whereas by qualitative nPCR HCMV DNA could be detected in PBL extracts of a single HCMV IgG seropositive blood donor (data not shown).
Discussion
The exact quantitative determination of limited numbers of RNA or DNA molecules is of great interest for many applications of PCR. Various strategies have been proposed to reach this experimental goal. Although easy to perform, a mere quantification of amplification products after PCR may lead to erroneous estimations of the target sequence number, especially when the nonexponential phase of PCR is reached or when reaction inhibitors are present in samples. Thus, relatively elaborate PCR protocols have to be followed to keep the amplification efficiency of individual reactions constant (Abbott et al., 1988; Bettens et al., 1991; Ferre et al., 1992; Holodniy et al., 1991 ; Landgraf et al., 1991 ; Oka et al., 1990) . Effects of varying amplification efficiency in PCR can be elegantly overcome by competitive PCR (Wang et al., 1989) .
There are two important aspects that should be considered if competitive PCR is employed to quantify target sequences. Differences among st and target sequences must be minimal to guarantee identical amplification rates of both sequences. On the other hand, post-PCR detection of amplimers should permit a reliable discrimination of st and wt amplimers.
The use of internal st sequences that generate PCR amplimers differing in length from amplified wt sequences provides a simple way to separate and detect PCR products on ethidium bromide-stained agarose gels (Menzo et al., 1992; Scadden et al., 1992) . Significant differences in amplimer length, however, may result in altered amplification efficiencies during PCR.
As an alternative way to discriminate amplified target sequences from st sequences, recognition sites of a restriction enzyme or a DNA-binding protein present either in the st or the target sequence may be used (Fox et al., 1992; Lundeberg et al., 1991; Stieger et al., 1991) . Without the use of labelled probes in post-PCR detection steps, however, formation of heteroduplexes between st and st amplimers during PCR may lead to significant errors (Becker-Andr~ & Hahlbrock, 1989) . Recently, a modified solid-phase minisequencing protocol has been proposed for the measurement of target sequences (Ikonen et al., 1992) . This rather elaborate approach uses an internal st differing from the wt target sequences by a single base exchange.
In the present study, we tested the capacity of nPCR/TGGE to detect and quantify limited amounts of HCMV target sequences in clinical specimens. According to previously published data (Henco & Heibey, 1990) , the accuracy of then PCR/TGGE is high, i.e. error rates were typically below 5 %. Depending on the number of st sequences used, fewer than 10 molecules of the HCMV target sequence can be detected and quantified in nPCR/TGGE. However, errors increase owing to uneven distribution of st and target sequences if very low amounts of target sequences are to be determined.
As a strategy to reduce effects of sample extraction on measurement of cell-associated viral target sequences, the additional quantification of a cellular single-copy gene (Kellog et at., 1990; Lee et at., 1991) and calculation of the ratio of HCMV sequences/cell genomes was evaluated. We found that the ratio of HCMV//~-globin sequences remained constant even when samples were serially diluted prior to PCR. Thus, the expression of virus load in peripheral blood or organ biopsies as the number of virus sequences per cellular genome should allow better comparability of quantitative PCR results.
Our data indicate that the use of nPCR/TGGE for diagnosis of HCMV infections offers several distinct advantages. Thus, even very limited amounts of the HCMV target sequences can be reliably detected and quantified. The co-amplification of a defined number of st sequences in each PCR permits a 'cut-off' approach in which the sensitivity of PCR is adjusted to a desired level. Depending on the clinical situation and type of specimens tested, this should help to minimize unwanted positive PCR results, due for example to the presence of low levels of the target sequence in latently infected healthy individuals. As demonstrated for a small number of HCMV PCR-positive renal transplant recipients, measurement of HCMV target sequences in PBL extracts reduces the number of 'false positive' PCR results. Furthermore, high ratios of HCMV sequences/fl-globin sequences seem to correlate which clinically symptomatic HCMV infections.
To allow a better demonstration of the diagnostic significance of quantitative HCMV PCR, we are currently performing a prospective study with a higher number of renal allograft recipients. However, despite the low number of patients and clinical specimens so far tested, it is concluded that nPCR/TGGE improves the diagnosis of HCMV infection. It may also be useful for detection of other viral infections by PCR in the immunocompromised host.
